I know that the 200,000 vials are going to the PI's and
I know that the 200,000 vials are going to the PI's and it's not an EUA there, but just a distribution supply agreement yet, shares are still getting pummeled by traders. We hit a high of 3.29 today and here we are back fighting for the $3.00 mark yet again, currently at 3.05. And this happens all the time when we print news of more success. It's like the old commercial of a product that say's " and so on, and so on and so on and we get pummeled time after time as if no news was released of the good that CYDY is doing.
WHO is doing this and why? That is the $64,000 question. I have always and still say it's some one or some group of brokers/traders that do not want Cytodyn to have any kind of success in the pharmaceutical industry. Nefarious? Oh yeah it is. Some one or some group of people surely have deep pockets to persuade traders to stop any forward movement of our shares as to keep us behind the curtain so no investors or new investors can see the progress of what Leronlimab/Vyrologix has been able to attain so far.
What CYDY needs is an investor or a group of investors just like those that are pounding us into the deep zone, day after day to combat these entities the other way, up, just deep pockets of money to stop this incessant supply of sellers. I don't know what else to say as it just does not make sense with the progress CYDY has had as each day passes that we continually have forces to stop this company dead it it's tracks.
We need buyers to change the direction of our shares. I firmly believe that our share price with all the good news we continue to get, shares should be up and around 6.00/share, at least if not more. To get this, we need to broadcast our progress and defy the agencies and blast our success loud and clear otherwise we will sit here until substantial news and I mean BIG news like an EUA, somewhere on this planet to stop this onslaught of these traders and brokers or whom ever is doing this, ugh!
GLTA
HCIT
8
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Mark Your Calendars, Investors! Folks grumble about the mundane task of checking fiscal calendars, but without this intel, where are we? On November 17, 2026, Palatin Technologies (NASDAQ:PTN) is slated to release their Q1 Fiscal Year 2027 operating results bright and early, before most of us have even sipped our coffee. The buzz around these numbers is as electric as any...
Continue Reading
Setting the Stage for Rheumatic Disease Breakthroughs Innovent Biologics is coming out of the gates hot with its recent presentation at the ACR Convergence 2026, delivering some jaw-dropping preclinical data on its fledgling bispecific antibody, IAR177. Situated in Orlando, this showcase sounds like a real advancement in tackling the uphill battle of rheumatic diseases....
Continue Reading
Allstate Keeps the Dividend Train Rolling in 2027 Today, Allstate Corporation is back in the headlines, and no, it's not about any flashy new product or some flashy CEO speech. It's about cold, hard cash making its way into investors' pockets. The board just gave the nod to a quarterly dividend of $1.08 per share, slated to hit the books on January 4, 2027. If you're...
Continue Reading
Everest Group's Legal Storm: A Call to Action Jumping straight into the proverbial storm, Everest Group, Ltd. (NYSE:EG) is snagged in a mess of their own creation, leaving investors holding the short end of the stick. This class action suits up post-haste, citing a cocktail of mismanagement and downright dodgy disclosures regarding their U.S. casualty insurance gambit....
Continue Reading
Why Morgan County? A Question for Homebuyers Ever wondered what makes Morgan County, IN, such a hot ticket for folks looking to escape the daily grind of big city life? Rachel Blacklidge, real estate wizard and hometown hero, lays it all out in a way even the most city-bound among us can appreciate. Small-Town Vibes, Big-City Access Let’s face it—sometimes the chaos...
Continue Reading
A Shift in the Esports Betting Landscape Well, it looks like we’ve hit another significant milestone in the esports betting universe. Sportradar, the sports tech giant known for pushing boundaries, has forged an intriguing alliance with DATA.BET, a sportsbook hotshot hailing from Cyprus. We're talking about a deal that’s set to shake up the esports betting scene with...
Continue Reading
A New Wave in Northeast Florida Bet you didn't expect to hear about pool care while sipping your morning coffee, but here we are. Poolwerx, the heavyweight champion in the pool service world, is pumping up its presence in the Northeast Florida landscape. Guess who’s the man behind this expansion? Matt Feldt, a Navy vet who’s traded in sonar for skimmers, has opened...
Continue Reading
Tony Leung Steals the Spotlight In the theater of Asian cinema, Tony Ka-fai Leung delivers a top-tier performance, earning him the Best Actor award at the Golden Rooster Awards for iQIYI's film "The Shadow's Edge." Now, let's not kid ourselves, snagging one of these prestigious awards is no walk in the park. It's fair to say both this recognition and his first-time win at...
Continue Reading
Redefining AI Infrastructure with LITEON Strolling through the electronica 2026 event in Munich, you can't help but notice LITEON flexing its muscles in the AI space. No fluffy marketing talk here—it's all about hard-core tech stats and future-proofing AI infrastructure. They're touting AI innovations that scale from cloud juggernauts to nimble edge applications, which...
Continue Reading
Choosing the Right Learning Tools for Strategic Growth Trying to solve today's HR challenges with yesterday's tools is like using a hammer to fix your computer. In the rapidly evolving landscape of learning technologies, McLean & Company is passing along a crucial piece of advice: focus on strategy, not just on loading up features. Nailing Down Organizational Priorities...
Continue Reading
Top 5 Most Recently Viewed Articles
Exciting Collaboration Between Tonix Pharmaceuticals and X-Chem In a groundbreaking move, Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) has announced a strategic collaboration with X-Chem, Inc. to harness the power of artificial intelligence (AI) and machine learning (ML) in developing broad-spectrum antiviral medications. This partnership aims not only to accelerate...
Continue Reading
Strategic Partnership in U.S. Manufacturing SKYX Technologies (NASDAQ: SKYX), a pioneering firm in advanced home technology, has recently taken a significant leap forward by establishing a partnership with Profab Electronics. This partnership is aimed at enhancing the manufacturing landscape in the United States, ensuring that SKYX can deliver its innovative products...
Continue Reading
Gevo's Business Update: Vision for 2025 Gevo, Inc. (NASDAQ: GEVO) has provided an exciting overview of its business strategy, aiming for substantial growth in 2025. The company, renowned for its commitment to renewable hydrocarbon fuels and chemicals designed to reduce greenhouse gas emissions, has set a clear trajectory towards achieving a positive run-rate Adjusted...
Continue Reading
Picton Mahoney Asset Management Announces Monthly Cash Distribution Picton Mahoney Asset Management is excited to announce its latest monthly cash distribution for the ETF units across its various funds. This month, the firm has declared a distribution of $0.0359 per unit for the units of the Picton Mahoney Fortified Income Alternative Fund. Update on Special Situations...
Continue Reading
Portland General Electric's Commitment to Clean Energy In 2024, Portland General Electric (PGE) announced remarkable growth in clean energy resources, becoming a leading force in sustainable power generation. The company reported that a striking 45% of its energy generation and procurement originated from non-carbon-emitting resources. This achievement marks a 7% increase...
Continue Reading